Prognostic significance of monocytosis in patients with myeloproliferative disorders

Miloslav Beran, Yu Shen, Francesco Onida, Sijin Wen, Hagop Kantarjian, Elihu Estey

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Based on clinical and pathological findings, chronic myelomonocytic leukemia (CMML) differs from other myeloproliferative/myelodysplastic disorders by its hallmark, monocytosis. It is unknown whether the presence of monocytosis and the diagnosis of CMML carry a prognostic significance. The present study aimed to determine whether the survival of patients with CMML differs from that of patients with BCR/ ABL-negative CML or Ph1-, BCR/ABL-unknown CML, once other potentially prognostic variables have been accounted for. The records of 485 patients with myeloproliferative/myelodysplastic disorders [CMML, n = 304; BCR/ABL-negative CML, n = 107; Ph1-, BCR/ABL unknown, n = 74] were analysed. Of the covariates found to be significantly (P <0.01) associated with survival in univariate and multivariate analyses, the following remainedpredictive and adversely associated with survival in univariate and multivariate analysies, the following remained predictive and adversely associated with survival, after accounting for the influence of other covaries: increasing age, white blood cell count, platelets, bone marrow blasts and cellularity, decreasing hemoglobin, abnormal karyotype, and diagnosis of CMML. The diagnosis of CMML is prognostically significant and independently associated with a shorter survival and a higher risk of death than BCR/ ABL-negative CML or Ph1- BCR/ABL-unknown CML.

Original languageEnglish
Pages (from-to)417-423
Number of pages7
JournalLeukemia and Lymphoma
Volume47
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Leukemia, Myelomonocytic, Chronic
Myeloproliferative Disorders
Survival
Abnormal Karyotype
Leukocyte Count
Hemoglobins
Blood Platelets
Multivariate Analysis
Bone Marrow

Keywords

  • MPD
  • Prognostic significance of monocytosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Prognostic significance of monocytosis in patients with myeloproliferative disorders. / Beran, Miloslav; Shen, Yu; Onida, Francesco; Wen, Sijin; Kantarjian, Hagop; Estey, Elihu.

In: Leukemia and Lymphoma, Vol. 47, No. 3, 03.2006, p. 417-423.

Research output: Contribution to journalArticle

Beran, Miloslav ; Shen, Yu ; Onida, Francesco ; Wen, Sijin ; Kantarjian, Hagop ; Estey, Elihu. / Prognostic significance of monocytosis in patients with myeloproliferative disorders. In: Leukemia and Lymphoma. 2006 ; Vol. 47, No. 3. pp. 417-423.
@article{2c55a93c8201443f809c162f35a02238,
title = "Prognostic significance of monocytosis in patients with myeloproliferative disorders",
abstract = "Based on clinical and pathological findings, chronic myelomonocytic leukemia (CMML) differs from other myeloproliferative/myelodysplastic disorders by its hallmark, monocytosis. It is unknown whether the presence of monocytosis and the diagnosis of CMML carry a prognostic significance. The present study aimed to determine whether the survival of patients with CMML differs from that of patients with BCR/ ABL-negative CML or Ph1-, BCR/ABL-unknown CML, once other potentially prognostic variables have been accounted for. The records of 485 patients with myeloproliferative/myelodysplastic disorders [CMML, n = 304; BCR/ABL-negative CML, n = 107; Ph1-, BCR/ABL unknown, n = 74] were analysed. Of the covariates found to be significantly (P <0.01) associated with survival in univariate and multivariate analyses, the following remainedpredictive and adversely associated with survival in univariate and multivariate analysies, the following remained predictive and adversely associated with survival, after accounting for the influence of other covaries: increasing age, white blood cell count, platelets, bone marrow blasts and cellularity, decreasing hemoglobin, abnormal karyotype, and diagnosis of CMML. The diagnosis of CMML is prognostically significant and independently associated with a shorter survival and a higher risk of death than BCR/ ABL-negative CML or Ph1- BCR/ABL-unknown CML.",
keywords = "MPD, Prognostic significance of monocytosis",
author = "Miloslav Beran and Yu Shen and Francesco Onida and Sijin Wen and Hagop Kantarjian and Elihu Estey",
year = "2006",
month = "3",
doi = "10.1080/10428190500305448",
language = "English",
volume = "47",
pages = "417--423",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Prognostic significance of monocytosis in patients with myeloproliferative disorders

AU - Beran, Miloslav

AU - Shen, Yu

AU - Onida, Francesco

AU - Wen, Sijin

AU - Kantarjian, Hagop

AU - Estey, Elihu

PY - 2006/3

Y1 - 2006/3

N2 - Based on clinical and pathological findings, chronic myelomonocytic leukemia (CMML) differs from other myeloproliferative/myelodysplastic disorders by its hallmark, monocytosis. It is unknown whether the presence of monocytosis and the diagnosis of CMML carry a prognostic significance. The present study aimed to determine whether the survival of patients with CMML differs from that of patients with BCR/ ABL-negative CML or Ph1-, BCR/ABL-unknown CML, once other potentially prognostic variables have been accounted for. The records of 485 patients with myeloproliferative/myelodysplastic disorders [CMML, n = 304; BCR/ABL-negative CML, n = 107; Ph1-, BCR/ABL unknown, n = 74] were analysed. Of the covariates found to be significantly (P <0.01) associated with survival in univariate and multivariate analyses, the following remainedpredictive and adversely associated with survival in univariate and multivariate analysies, the following remained predictive and adversely associated with survival, after accounting for the influence of other covaries: increasing age, white blood cell count, platelets, bone marrow blasts and cellularity, decreasing hemoglobin, abnormal karyotype, and diagnosis of CMML. The diagnosis of CMML is prognostically significant and independently associated with a shorter survival and a higher risk of death than BCR/ ABL-negative CML or Ph1- BCR/ABL-unknown CML.

AB - Based on clinical and pathological findings, chronic myelomonocytic leukemia (CMML) differs from other myeloproliferative/myelodysplastic disorders by its hallmark, monocytosis. It is unknown whether the presence of monocytosis and the diagnosis of CMML carry a prognostic significance. The present study aimed to determine whether the survival of patients with CMML differs from that of patients with BCR/ ABL-negative CML or Ph1-, BCR/ABL-unknown CML, once other potentially prognostic variables have been accounted for. The records of 485 patients with myeloproliferative/myelodysplastic disorders [CMML, n = 304; BCR/ABL-negative CML, n = 107; Ph1-, BCR/ABL unknown, n = 74] were analysed. Of the covariates found to be significantly (P <0.01) associated with survival in univariate and multivariate analyses, the following remainedpredictive and adversely associated with survival in univariate and multivariate analysies, the following remained predictive and adversely associated with survival, after accounting for the influence of other covaries: increasing age, white blood cell count, platelets, bone marrow blasts and cellularity, decreasing hemoglobin, abnormal karyotype, and diagnosis of CMML. The diagnosis of CMML is prognostically significant and independently associated with a shorter survival and a higher risk of death than BCR/ ABL-negative CML or Ph1- BCR/ABL-unknown CML.

KW - MPD

KW - Prognostic significance of monocytosis

UR - http://www.scopus.com/inward/record.url?scp=30844431784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30844431784&partnerID=8YFLogxK

U2 - 10.1080/10428190500305448

DO - 10.1080/10428190500305448

M3 - Article

C2 - 16396764

AN - SCOPUS:30844431784

VL - 47

SP - 417

EP - 423

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -